NTSR1 and neoplasm: Similarly, significant decrease in NTR+ tumour SUVmax values was also noted in 18F-FMISO PET contrast performed at day 3 in comparison to pre-treatment SUVmax values (SUVmax 4.07 ± 0.23 and 3.19 ± 0.41 g/mL; p < 0.001).